Authors

• Weiping Deng (ORCID: https://orcid.org/0000-0002-9825-3297)
• Spyros Chalkias (ORCID: https://orcid.org/0000-0002-6254-1158)
• Yamuna Devi Paila
• Jay Meyer
• Jing Feng (ORCID: https://orcid.org/0009-0007-7841-291X)
• Jacqueline M. Miller (ORCID: https://orcid.org/0000-0002-7083-2182)
• Madhavi Ampajwala
• Lorraine Schoch
• Darin K. Edwards (ORCID: https://orcid.org/0000-0002-2065-2941)
• Elizabeth de Windt
• Rituparna Das (ORCID: https://orcid.org/0000-0002-5166-0311)
• Gary Berman (ORCID: https://orcid.org/0000-0002-9297-9476)
• Adebayo Akinsola
• Wen Zhou
• Antionette Pragalos

Institutions

• Clinical Research Institute (US)
• Clinical Trials of Texas (US)
• Clinical Trial and Consulting (US)
• Moderna Therapeutics (United States) (US)
• Velocity Clinical Research (United States) (US)
• University of Atlanta (US)

Publication Details

Journal

The Journal of Infectious Diseases

Published

2025-01-10

DOI

https://doi.org/10.1093/infdis/jiaf022

Citations

12

Primary Topic

SARS-CoV-2 and COVID-19 Research

Type

article

Field-Weighted Citation Impact

16.75

Funders

• Moderna